Dr Bok S Ahn, MD in Chappaqua, NY - Pain Medicine

Dr Bok S Ahn, MD is a Pain Medicine - Pain Medicine physician based in Chappaqua, New York. Dr Bok S Ahn is licensed to practice in New York (license number 103025) and her current practice location is 639 Quaker Rd, Chappaqua, New York. She can be reached at her office (for appointments etc.) via phone at (914) 238-0207.

NPI number for Dr Bok S Ahn is 1073887097 and her current mailing address is 639 Quaker Rd, Chappaqua, New York. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1073887097.

Contact Information

	Dr Bok S Ahn, MD
	639 Quaker Rd, Chappaqua, NY 10514-1507
	(914) 238-0207
	Not Available

Physician's Profile

Full Name	Dr Bok S Ahn
Gender	Female
Speciality	Pain Medicine - Pain Medicine
Location	639 Quaker Rd, Chappaqua, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1073887097
Provider Enumeration Date: 03/08/2012
Last Update Date: 03/08/2012

Medical Identifiers

Medical identifiers for Dr Bok S Ahn such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1073887097	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208VP0000X	Pain Medicine - Pain Medicine	103025 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Bok S Ahn is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Bok S Ahn, MD 639 Quaker Rd, Chappaqua, NY 10514-1507 Ph: (914) 238-0207	Dr Bok S Ahn, MD 639 Quaker Rd, Chappaqua, NY 10514-1507 Ph: (914) 238-0207

News Archive

Alder Biopharmaceuticals reports positive data from ALD518 Phase 2a clinical trial for NSCLC

Alder Biopharmaceuticals Inc. today announced that patients with late-stage non-small cell lung cancer (NSCLC) showed improvement in cancer-related anemia and symptoms of the disease in a Phase 2a clinical trial of ALD518, a monoclonal antibody directed against interleukin-6 (IL-6).

Abused children more likely to suffer fingertip injuries, study finds

Many children who suffer fingertip injuries have been abused, according to a Rutgers study. The researchers found that children who had a documented history of abuse or neglect were 23 percent more likely to suffer a fingertip injury before age 12.

Johns Hopkins members to be honored with American Academy of Nursing's Fellows recognition

Faculty members at the Johns Hopkins School of Nursing will be honored in all three categories of the American Academy of Nursing's Fellows recognition. Sharon Kozachik, PhD, RN, and Jennifer Wenzel, PhD, RN, CCM, will be inducted as Fellows, Laura Gitlin, PhD, will be awarded an Honorary fellowship, and Fannie Gaston-Johansson, PhD, RN, FAAN, will be recognized as a Living Legend—the academy's highest distinction.

Restaurants guilty of sponsoring "extreme eating" say food police

According to a consumer group in the U.S., chain restaurants are guilty of promoting "extreme eating" by offering patrons dishes loaded with calories.

Dr Bok S Ahn, MD - Pain Medicine in Chappaqua, NY